Infectious delivery of the 132 kb CDKN2A/CDKN2B genomic DNA region results in correctly spliced gene expression and growth suppression in glioma cells

This publication has 41 references indexed in Scilit:

• Progress and problems with the use of viral vectors for gene therapy
  Nature Reviews Genetics, 2003
• Primary brain tumours in adults
  The Lancet, 2003
• High-resolution genetic mapping of the ACE-linked QTL influencing circulating ACE activity
  European Journal of Human Genetics, 2002
• The INK4a/ARF network in tumour suppression
  Nature Reviews Molecular Cell Biology, 2001
• Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in Mice
  Molecular Therapy, 2001
• Making Sense of the Sequence
  Science, 2001
• Adenovirus-mediated transfer of p53 and p16INK4a results in pancreatic cancer regression in vitro and in vivo
  Gene Therapy, 2001
• Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53
  Gene Therapy, 2000
• Phenotype vs Genotype in the Evolution of Astrocytic Brain Tumors
  Toxicologic Pathology, 2000
• Primary and secondary glioblastomas: From concept to clinical diagnosis
  Neuro-Oncology, 1999